Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on Monday March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...